Trial design
This trial is being organized by the Japanese Society for Denture Care, developed by KK, the principal investigator of the study, and conducted at eight centers (university hospitals). The trial is designed as a multicenter randomized parallel trial comparing patients' general satisfaction with mandibular CDs with RLs and that with mandibular CDs with NRLs.
The chief coordinators, SK, NH, and YS, are closely liaising with the coordinators at each center. Every center has its own coordinator and researcher. The coordinator randomly assigns as well as manages the schedules of participants and investigators. The investigators will receive training in assessing the outcomes of the trial, perform measurements, and record the data. Dentists who provided the denture treatment are not allowed to be investigators for this trial. The blinded digital data will be returned to the Chief Coordinator for analysis. This trial has been registered with the University Hospital Medical Information Network (UMIN) Center (UMIN000041950) on 10 October 2020.
Participants
The trial will be performed at the dental hospitals of eight universities in Japan. The recruitment and treatment protocols of the present trial have been approved by the ethical review committee of the following universities: Tokyo Medical and Dental University (Register No. D2020-058), Nihon University School of Dentistry at Matsudo (Register No. EC2-042), Tsurumi University (Register No. 1840), Kanagawa Dental University (Register No. 733), Aichi Gakuin University (Register No. 612), Tokushima University (Register No. 3855), Nagasaki University (Register No. 21041910), and Kagoshima University (Register No. 200313).
The inclusion criteria are as follows: (1) edentulous patients who wanted to have their mandibular CDs repaired and (2) patients who provided written informed consent for this study. The exclusion criteria are as follows: (1) patients with physical or mental problems, (2) patients who cannot hear or read Japanese, (3) patients with dietary restrictions, and (4) patients with oral dyskinesia.
Sample size calculation
The use of an RL material will be judged to be clinically effective when the general satisfaction (100 mm Visual Analog Scale [VAS] score after 3 months of relining) of patients having CDs with RL is 15 mm higher than that of patients having CDs with NRL. The difference between the means of the two groups is set to 15 mm. The sample size is calculated using α = 0.05 and β = 0.8, based on the standard deviation of the overall satisfaction obtained in a previous study (CDs with RL: 26.3, CDs with NRL: 31.4) [7]. However, assuming that 10% of the participants would drop out, the target number of participants has been set at 132.
Randomization and masking
Stratification is performed at each university hospital (Fig. 1). The assignment is performed by a block randomization method with a block size of 2. For this purpose, random numbers from 1 to 6 representing combinations of 2 RLs and 2 NRLs: 1 (NRL, NRL, RL, RL), 2 (NRL, RL, NRL, RL), 3 (NRL, RL, RL, NRL), 4 (RL, NRL, NRL, RL), 5 (RL, NRL, RL, NRL), and 6 (RL, RL, NRL, NRL) are generated in Excel (Microsoft, USA) to create an allocation table. Kanagawa Dental University will centrally manage the allocation list for each center, and the coordinator of each center will contact the Chief Coordinator of Kanagawa Dental University by e-mail with each patient’s registration details to determine the intervention method. Both patients and dentists in this trial will not be blinded to the intervention, but will be blinded to the outcome measures and analysis.
[Figure 1 near here]
Intervention
The intervention for this trial will be the application of an RL material (Reline 2 Extra Soft; GC, Tokyo, Japan) or an NRL material (Rebase III [Normal]; Tokuyama Dental, Tokyo, Japan) to the mandibular CD. The lining method in this trial is indirect with the application of dynamic impression. Tissue conditioner (Tissue Conditioner II Soft; Shofu, Kyoto, Japan; Tissue Conditioner; GC, Tokyo, Japan) will be used for recording the dynamic impression. All prosthetic procedures will be performed by a prosthodontist with at least 5 years of experience. In principle, the indirect method should be performed by a dental technician. The technique used is as follows:
-
A dynamic impression is made using a tissue conditioner on the CD to be indirectly relined. The dynamic impression should be recorded when the patient does not complain of pain during mastication. Considering the surface properties of the tissue conditioner, an interval of approximately one week is appropriate.
-
A super-hard plaster (New Fuji Rock; GC, Tokyo, Japan) is poured on the dynamic impression surface to make a plaster model, which is flasked for denture processing.
-
The flask is opened, the tissue conditioner is peeled off from the mucosal surface of the model, and the mucosal surface of the denture base is trimmed to create space for the reline layer. The thickness of the reline layer is approximately 2 mm.
-
After applying the adhesive material according to the manufacturer's instructions, the CD is lined with the relining material (RL or NRL), cured, morphed, and polished. The relined CD is then delivered to the patient. Post-denture delivery follow-up appointments will be scheduled, and any necessary adjustments will be carried out.
Outcomes
The basic patient information recorded would include age, sex, years of denture use, and number of dentures fabricated. In addition, treatment difficulty index measurements [14, 15] and evaluation of used dentures [16] will also be performed. Since patient satisfaction with CDs is clinically important in evaluating the therapeutic effect of CDs with RL, the primary endpoint will be patients’ overall satisfaction with the CDs, which will be determined using a 100-mm VAS [17]. Patient satisfaction will be assessed comprehensively using a questionnaire containing eight assessment items: general satisfaction, ease of speaking, ease of cleaning, retention, stability, comfort, and esthetics. Participants will be asked to rate their satisfaction with each item in the questionnaire by using a 100-mm VAS to evaluate their current CDs. Data will be recorded as continuous variables at 1-mm intervals by using calipers from the left end. Overall patient satisfaction will be measured four times: at baseline, 7 days, 3 months, 6 months, and 1 year.
In addition, to comprehensively understand the clinical effect of CDs with RL material, the oral health-related quality of life [18], masticatory ability [19, 20], food intake [21, 22], and the location and number of mucosal pressure ulcers will be examined as secondary outcomes. Photographs of mucosal pressure ulcers will be shared among investigators to sufficiently calibrate assessments of the mucosal surface (Fig. 2).
[Figure 2 near here]
Response to adverse events
The principal investigator, a dentist, will carefully monitor the occurrence of adverse events. If an adverse event occurs, appropriate measures will be taken and, in principle, the patients will be observed until the events disappear. The type of event, date of occurrence (or the date of the hospital visit when the event was detected), treatment (continuation, discontinuation, etc.), course of the adverse event, and causal relationship to the resilient liners will be described in great detail. Observation will continue until one year after the resilient liner will be applied, and this also accounts for the entire duration of the trial.
Data handling
The study coordinators and dentists at each university will identify patients using registration numbers and initials during the duration of data preparation and handling. They will also take into consideration the protection of patient confidentiality. All of the personnel involved in this study will not be permitted to divulge, without justifiable cause, any confidential information about the individuals involved in the study.
The collected data from each university will be gathered and stored at the Center for the Promotion of Clinical Research (Kanagawa Dental University). The collected data will be analyzed by the chief coordinators after confirmation is given by the chief investigator. All materials used in the study will be stored for three years after the completion or discontinuation of the study.
Access to the final clinical trial data will be limited to the chief investigator and chief coordinators.
Clinical Trials Committee
A clinical trial committee will be established for this clinical trial. This committee will meet on a regular basis. The members of this committee will consist of the chief investigator, chief coordinators, and coordinators from each university. The role of this committee is to audit the progress of the clinical trial, report adverse events, and discuss and decide on important changes to the protocol.
Statistical analysis
The statistical analyses will be performed as follows:
-
Normality will be confirmed by the Kolmogorov–Smirnov test, and either parametric or nonparametric tests will be performed.
-
Between-group comparisons will be made using Student’s t-test or Mann-Whitney U test, depending on the distribution of the outcome.
-
Within-group comparisons will be performed using the paired t-test or Wilcoxon's signed-rank test depending on the distribution of outcomes.
-
Chi-square test will be used to test the proportions.
-
The significance level will be set at 5% on both sides, and p-values will be adjusted by Bonferroni's correction to account for multiplicity when more than three groups are compared.
-
The significance level will be 5% two-sided.